178 related articles for article (PubMed ID: 37125336)
21. [Effect of moxibustion combined with benazepril on expression of IL-18 and phosphorylated protein kinase B in myocardial tissue of rats with chronic heart failure].
Wang W; Li QL; Ma Q; Xia R; Gao B; Wang Y; Wang J
Zhen Ci Yan Jiu; 2021 Nov; 46(11):935-41. PubMed ID: 34865330
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
Abbas NAT; Kabil SL
Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
[TBL] [Abstract][Full Text] [Related]
23. Thioredoxin Reductase 2 Synergizes with Cytochrome c, Somatic to Alleviate Doxorubicin-Induced Oxidative Stress in Cardiomyocytes and Mouse Myocardium.
Li C; Lai H; Cai X; Liu Y; Hong L; Huang X; Shao L
Int Heart J; 2023 Mar; 64(1):60-70. PubMed ID: 36725079
[TBL] [Abstract][Full Text] [Related]
24. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
[TBL] [Abstract][Full Text] [Related]
25. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
Yu JL; Jin Y; Cao XY; Gu HH
Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
[TBL] [Abstract][Full Text] [Related]
26. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity.
Naderi Y; Khosraviani S; Nasiri S; Hajiaghaei F; Aali E; Jamialahmadi T; Banach M; Sahebkar A
Biomed Pharmacother; 2023 Feb; 158():114055. PubMed ID: 36495663
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
[TBL] [Abstract][Full Text] [Related]
28. Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway.
Chen L; Qin Z; Ruan ZB
PeerJ; 2023; 11():e15315. PubMed ID: 37220525
[TBL] [Abstract][Full Text] [Related]
29. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
[TBL] [Abstract][Full Text] [Related]
30. Shengxian decoction protects against chronic heart failure in a rat model via energy regulation mechanisms.
Yang ZQ; Han YY; Gao F; Tian JY; Bai R; Guo QH; Liu XC
BMC Complement Med Ther; 2023 Jun; 23(1):200. PubMed ID: 37330478
[TBL] [Abstract][Full Text] [Related]
31. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z
Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843
[TBL] [Abstract][Full Text] [Related]
32. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity
Hu C; Zhang X; Wei W; Zhang N; Wu H; Ma Z; Li L; Deng W; Tang Q
Acta Pharm Sin B; 2019 Jul; 9(4):690-701. PubMed ID: 31384530
[TBL] [Abstract][Full Text] [Related]
33. Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J; De Rosa S; Tammè L; Iaconetti C; Sorrentino S; Polimeni A; Mignogna C; Amorosi A; Spaccarotella C; Yasuda M; Indolfi C
Cardiovasc Diabetol; 2020 May; 19(1):66. PubMed ID: 32414364
[TBL] [Abstract][Full Text] [Related]
34. Combination of nicotinamide mononucleotide and troxerutin induces full protection against doxorubicin-induced cardiotoxicity by modulating mitochondrial biogenesis and inflammatory response.
Khosroshahi AJ; Mokhtari B; Badalzadeh R
Mol Biol Rep; 2022 Sep; 49(9):8209-8218. PubMed ID: 35842854
[TBL] [Abstract][Full Text] [Related]
35. Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction.
Chen X; Tian C; Zhang Z; Qin Y; Meng R; Dai X; Zhong Y; Wei X; Zhang J; Shen C
Front Biosci (Landmark Ed); 2023 Mar; 28(3):45. PubMed ID: 37005753
[TBL] [Abstract][Full Text] [Related]
36. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
[TBL] [Abstract][Full Text] [Related]
37. Octreotide protects doxorubicin-induced cardiac toxicity via regulating oxidative stress.
Dai GF; Wang Z; Zhang JY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6139-6148. PubMed ID: 30280802
[TBL] [Abstract][Full Text] [Related]
38. Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.
Barış VÖ; Dinçsoy AB; Gedikli E; Zırh S; Müftüoğlu S; Erdem A
Cardiovasc Toxicol; 2021 Sep; 21(9):747-758. PubMed ID: 34089496
[TBL] [Abstract][Full Text] [Related]
39. Ferruginol Restores SIRT1-PGC-1α-Mediated Mitochondrial Biogenesis and Fatty Acid Oxidation for the Treatment of DOX-Induced Cardiotoxicity.
Li W; Cao J; Wang X; Zhang Y; Sun Q; Jiang Y; Yao J; Li C; Wang Y; Wang W
Front Pharmacol; 2021; 12():773834. PubMed ID: 34899332
[No Abstract] [Full Text] [Related]
40. Mesenchymal stem cells pretreated with platelet-rich plasma modulate doxorubicin-induced cardiotoxicity.
Zaki SM; Algaleel WA; Imam RA; Abdelmoaty MM
Hum Exp Toxicol; 2019 Jul; 38(7):857-874. PubMed ID: 30991846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
